India to sharply hike drug, vaccine testing fees at govt labs from August
Under the plan, the health and family welfare ministry has issued the Drugs (Third Amendment) Rules, 2026, establishing a uniform pricing model designed to match the actual, rising costs of modern testing. The new regulations replace the fee schedules under the legacy Drugs Rules, 1945, a move set to significantly impact the country’s $50 billion pharmaceutical industry.
Post Comment